Viewing data from:

HALDOL SOLUTAB

NDA

HALOPERIDOL | N017079 | ORTHO MCNEIL PHARMACEUTICAL INC

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain7 active DMFs6 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVHALOPERIDOL

DMF 49911983

JANSSEN PHARMACEUTICA NVHALOPERIDOL (R001625) DRUG SUBSTANCE

DMF 109461994

EXCELLA GMBH AND CO KGHALOPERIDOL

DMF 142261999

OLON SPAHALOPERIDOL

DMF 245852011

MSN LIFE SCIENCES PRIVATE LTDHALOPERIDOL USP

DMF 336922019

MANKIND PHARMA LTDHALOPERIDOL USP

DMF 341902019

VAMSI LABS LTDHALOPERIDOL USP

DMF 342832019

A NATTERMANN AND CIE GMBHInactiveHALOPERIDOL

DMF 53641984

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVInactiveHALOPERIDOL

DMF 62001986

IMHAUSEN CHEMIE GMBHInactiveHALOPERIDOL

DMF 68001987

GD SEARLE AND COInactiveHALOPERIDOL

DMF 71571987

HEUMANN PCS GMBHInactiveHALOPERIDOL

DMF 74861988

RPG LIFE SCIENCES LTDInactiveHALOPERIDOL USP

DMF 233112009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.